VistaGen Therapeutics, Inc. (VTGN) DCF Valuation

VistaGen Therapeutics, Inc. (VTGN) DCF Valuation
  • ✓ Entièrement Modifiable: Adapté À Vos Besoins Dans Excel Ou Sheets
  • ✓ Conception Professionnelle: Modèles Fiables Et Conformes Aux Normes Du Secteur
  • ✓ Pré-Construits Pour Une Utilisation Rapide Et Efficace
  • ✓ Aucune Expertise N'Est Requise; Facile À Suivre

VistaGen Therapeutics, Inc. (VTGN) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Discover the true potential of VistaGen Therapeutics, Inc. (VTGN) with our advanced DCF Calculator! Adjust key assumptions, explore various scenarios, and evaluate how shifts influence VistaGen's valuation – all within one convenient Excel template.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2020		 AY2
2021		 AY3
2022		 AY4
2023		 AY5
2024		 FY1
2025		 FY2
2026		 FY3
2027		 FY4
2028		 FY5
2029
Revenue .0 1.1 1.1 -.2 1.1 .5 .3 .1 .1 .0
Revenue Growth, % 0 0 1.78 -120.47 -568.72 -49.55 -49.55 -49.55 -49.55 -49.55
EBITDA -20.7 -17.4 -47.0 -58.7 -32.5 -.1 -.1 .0 .0 .0
EBITDA, % 100 -1600.83 -4242.75 25874.89 -3050.09 -20 -20 -20 -20 -20
Depreciation .1 .5 .7 .5 .6 .2 .1 .0 .0 .0
Depreciation, % 100 43.84 64.13 -234.36 53.38 32.27 32.27 32.27 32.27 32.27
EBIT -20.8 -17.9 -47.8 -59.3 -33.0 -.1 -.1 .0 .0 .0
EBIT, % 100 -1644.66 -4306.88 26109.25 -3103.48 -20 -20 -20 -20 -20
Total Cash 1.4 103.1 68.1 16.6 119.2 .3 .2 .1 .0 .0
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables .0 .0 .0 .0 .0
Account Receivables, % 100 3.73 0 0 0
Inventories .0 .9 2.5 -.7 .0 .4 .2 .1 .1 .0
Inventories, % 100 86.48 221.21 324.05 0 77.3 77.3 77.3 77.3 77.3
Accounts Payable 1.8 .8 2.8 2.5 1.5 .3 .1 .1 .0 .0
Accounts Payable, % 100 76.94 248.77 -1089.43 145.39 55.39 55.39 55.39 55.39 55.39
Capital Expenditure .0 -.3 -.2 -.2 -.1 -.1 .0 .0 .0 .0
Capital Expenditure, % 100 -25.28 -18.07 93.39 -5.73 -9.82 -9.82 -9.82 -9.82 -9.82
Tax Rate, % -0.01362491 -0.01362491 -0.01362491 -0.01362491 -0.01362491 -0.01362491 -0.01362491 -0.01362491 -0.01362491 -0.01362491
EBITAT -20.8 -17.9 -47.8 -59.3 -33.0 -.1 -.1 .0 .0 .0
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -18.8 -19.7 -46.8 -56.1 -34.2 -1.8 .1 .1 .0 .0
WACC, % 7.97 7.97 7.97 7.97 7.97 7.97 7.97 7.97 7.97 7.97
PV UFCF
SUM PV UFCF -1.4
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) 0
Terminal Value 0
Present Terminal Value 0
Enterprise Value -1
Net Debt -117
Equity Value 116
Diluted Shares Outstanding, MM 19
Equity Value Per Share 5.98

What You Will Get

  • Pre-Filled Financial Model: VistaGen’s actual data facilitates accurate DCF valuation.
  • Full Forecast Control: Modify revenue growth, profit margins, WACC, and other critical factors.
  • Instant Calculations: Automatic updates provide real-time results as you make adjustments.
  • Investor-Ready Template: A polished Excel file crafted for professional-level valuation.
  • Customizable and Reusable: Designed for adaptability, enabling repeated use for comprehensive forecasts.

Key Features

  • Comprehensive VTGN Data: Pre-filled with VistaGen Therapeutics’ historical performance metrics and future projections.
  • Customizable Input Parameters: Modify revenue growth rates, profit margins, discount rates, tax assumptions, and capital investments.
  • Adaptive Valuation Framework: Real-time updates to Net Present Value (NPV) and intrinsic value based on your adjustments.
  • Scenario Analysis: Develop various forecasting scenarios to evaluate different valuation possibilities.
  • Intuitive Interface: Clean, organized, and tailored for both industry experts and newcomers.

How It Works

  1. Download the Template: Gain immediate access to the Excel-based VTGN DCF Calculator.
  2. Input Your Assumptions: Modify the yellow-highlighted cells for growth rates, WACC, margins, and other variables.
  3. Instant Calculations: The model automatically calculates VistaGen's intrinsic value.
  4. Test Scenarios: Experiment with different assumptions to assess potential changes in valuation.
  5. Analyze and Decide: Utilize the results to inform your investment or financial analysis.

Why Choose This Calculator for VistaGen Therapeutics, Inc. (VTGN)?

  • User-Friendly Interface: Perfect for both novice and experienced users.
  • Customizable Inputs: Adjust parameters easily to suit your analysis needs.
  • Real-Time Feedback: Observe immediate updates to VistaGen’s valuation as you change inputs.
  • Preloaded Data: Comes with VistaGen’s actual financial information for swift evaluations.
  • Relied Upon by Experts: Favored by investors and analysts for making well-informed choices.

Who Should Use This Product?

  • Investors: Accurately assess VistaGen Therapeutics, Inc.'s (VTGN) fair value before making investment decisions.
  • CFOs: Utilize a professional-grade DCF model for financial reporting and analysis specific to biotech companies.
  • Consultants: Quickly customize the template for valuation reports tailored to clients in the pharmaceutical sector.
  • Entrepreneurs: Acquire insights into financial modeling practices utilized by leading biotech firms.
  • Educators: Employ it as a teaching resource to illustrate valuation methodologies in the life sciences industry.

What the Template Contains

  • Pre-Filled DCF Model: VistaGen Therapeutics’ (VTGN) financial data preloaded for immediate use.
  • WACC Calculator: Detailed calculations for Weighted Average Cost of Capital.
  • Financial Ratios: Evaluate VistaGen’s (VTGN) profitability, leverage, and efficiency.
  • Editable Inputs: Change assumptions such as growth, margins, and CAPEX to fit your scenarios.
  • Financial Statements: Annual and quarterly reports to support detailed analysis.
  • Interactive Dashboard: Easily visualize key valuation metrics and results.

No products were found matching.